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http://dx.doi.org/10.1016/j.asjsur.20Summary Primary melanoma of the esophagus is a rare condition. Its diagnosis can be chal-
lenging, as its presentation is similar to that of other esophageal malignancies, especially when
melanin is not evidently expressed in the melanoma. We report a case of esophageal mela-
noma in a 59-year-old Chinese male, whose histological diagnosis was confirmed from the eso-
phagectomy specimen.
Copyright ª 2012, Asian Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
First described by Baur in 1906,1 primary malignant
melanoma of the esophagus occurs very rarely, with an
incidence of 3.6 in 1 billion, and it contributes to 0.1e0.2%
of all esophageal neoplasms.2 From 2000 to 2011, of the
134 cases of esophagectomies performed in our institution
for esophageal carcinoma, only one had esophageal
melanoma; we herein present a case report of this
patient.ent of General Surgery,
Road, Singapore 169608,
com.sg (Y. Sim).
n Surgical Association. Published
12.11.0012. Case report
This is a case report of a 59-year-old Chinese male who
presented with a 2-week history of progressive dysphagia
without regurgitation and any other constitutional symp-
toms, and with no known medical history.
An esophagogastroduodenoscopy was performed, which
revealed a nonpigmented polypoidal mass 25 cm from the
incisor (Fig. 1), antral gastritis, and duodenitis. A biopsy of
the polypoidal mass revealed a poorly differentiated inva-
sive squamous cell carcinoma. Computed tomography
(Fig. 2) confirmed a large (4.3  2.1 cm2), homogenously
enhancing lobulated mass in the esophagus at the level of
the aortic arch, extending just distal to the carina, with
enlarged right upper paratracheal lymph nodesby Elsevier Taiwan LLC. All rights reserved.
Figure 1 Esophagogastroduodenoscopy illustrating the non-
pigmented polypoidal mass 25 cm from the incisor (red arrow).
A biopsy of the polypoidal mass revealed a poorly differenti-
ated invasive squamous cell carcinoma.
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A positron emission tomography (PET) scan further
demonstrated fluorodeoxyglucose (FDG) avidity only of this
esophageal mass and the right upper paratracheal lymph
nodes without any evidence of metastasis. A lung function
spirometry test was performed, whose results were within
normal limits; tracheoesophageal fistula and endobronchial
lesions were ruled out by bronchoscopy.
Although neoadjuvant chemoradiotherapy was offered
to downstage the disease, the patient opted to proceedFigure 2 Preoperative radiological imaging demonstrating the
tracheal lymph node. Computed tomography imaging confirmed (A
mass in the esophagus (marked by an asterisk) at the level of th
enlarged right upper paratracheal lymph node (2.0  1.5 cm2), and
avidity, respectively.directly with surgery. He underwent an elective three-
staged esophagectomy with an uncomplicated recovery. He
tolerated diet on Postoperative Day 8 and was discharged
home on Postoperative Day 10. Four months postsurgery,
a repeat PET scan shows no evidence of disease recurrence.
On gross examination, a brown-tan lobulated tumor
(4.5 cm) was noted in the distal esophagus. Histologic
examination revealed sheets of malignant cells displaying
epitheloid and spindle cell morphology, interspersed with
melanin pigments; adjacent mucosa showed melanocytic
proliferation with transepidermal migration (Fig. 3A).
Tumor cells displayed vesicular chromatin, prominent
nucleoli, and brisk mitotic activity (20e30/10 hpf). Immu-
nostains were positive for S100, HMB45, and Melan-A,
whereas cytokeratin markers were negative (Fig. 3B). The
right upper paratracheal lymph node was mostly replaced
by metastatic melanoma.3. Discussion
De la Pava et al3 first described the presence of melano-
cytes at the interface between the epithelium and the
lamina propria of the esophageal mucosa. Esophageal
melanosis, or melanocytosis, is a rare condition of benign
melanocytic proliferation found in 0.07e2.1% of gastros-
copies4,5 and is believed to be a precursor of primary
esophageal melanoma.6 Esophageal melanocytosis is asso-
ciated with chronic esophagitis, reactive epithelial
changes,4,5 LaugiereHunziker syndrome, and Addison’s
disease, and has been reported in patients with anal
melanoma,5 esophageal squamous cell carcinoma in situ,
and pulmonary adenocarcinoma.4patient’s esophageal carcinoma with an enlarged right para-
) a large (4.3  2.1 cm2), homogeneously enhanced lobulated
e aortic arch, extending just distal to the carina, and (B) an
(C and D) their corresponding PET images demonstrating FDG
Figure 3 Histopathological images of the esophageal tumor: (A) diffuse sheets of spindle and epitheloid melanocytic cells with
brisk mitoses and marked nuclear pleomorphism (400) and (B) diffuse and strong HMB45 staining of melanoma cells.
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larly to other esophageal malignancies. Endoscopically, it
often presents as a solitary polypoidal mass in the middle or
distal third of the esophagus, which may be pigmented or
nonpigmented, although multiple lesions have been re-
ported in 12% of cases.7 The challenge in clinching a histo-
logical diagnosis arises when the biopsy specimen lacks
melanin granules,6 misguiding the diagnosis as epithelial
carcinomas, although the latter typically present in the
proximal third of the esophagus. Likewise, the malignant
cells in our patient displayed a diversemorphology,making it
difficult to be identified from the initial biopsy and requiring
an en bloc resection to clinch the histological diagnosis.
Immunohistochemical staining of biopsy specimens with
melanocytic-specific markers such as HMB45 antibodies
can increase the accuracy of a pretreatment diagnosis;
however, one may question the efficacy of such a routine
screening stain, given the rarity of primary esophageal
melanomas. On presentation, metastatic disease is
present in approximately 50% of patients (31% hepatic, 29%
mediastinal, 18% pulmonary, and 13% cerebral),7 with
a mean survival rate of less than 5% at 5 years, a median
survival rate of 10 months, and a disease-related mortality
of 85%.2
The primary treatment is surgical excision with discre-
tionary lymphadenectomy for operable melanomas, with
total or near-total esophagectomy offering the best survival
outcome (5 years vs. 9 months for local resection).2 There is
a role for immunomodulatory therapy in patients with
metastatic disease and for palliative external beam radio-
therapy in those with unresectable esophageal mela-
nomas.8 Newer treatment modalities, such as intraluminal
brachytherapy and laser photoablation,9,10 have shown
great promise, but not without its potential toxicities, such
as esophagitis, ulcerations, strictures.
4. Conclusion
Primary melanoma of the esophagus is a rare condition that
may pose diagnostic difficulty, especially if it is non-
pigmented and lacks melanin granules in a biopsyspecimen. We propose that an esophageal melanoma be
considered as a differential diagnosis if the tumor is poly-
poidal. On diagnosis, one should rule out a primary mela-
noma peripherally, lest the management strategy be
altered for a metastatic melanoma. Total or near-total
esophagectomy offers the best survival outcome, and
newer adjuvant therapies such as brachytherapy and pho-
toablation show promising potential.
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